Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fennec Pharmaceuticals (FENC)
NASDAQ:FENC
RESEARCH TOOLSreports
Fennec Pharmaceuticals (FENC) Stock Price & Analysis
192 Followers
FENC Stock Chart & Stats
Day’s Range$9.05 - $9.61
52-Week Range― - ―
Previous Close$9.38
Volume288.71K
Average Volume (3M)N/A
Market Cap
$253.11M
Enterprise Value$269.57M
Total Cash (Recent Filing)$13.27M
Total Debt (Recent Filing)$29.73M
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 09, 2024EPS Estimate
-$0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue12.68
Enterprise Value/Gross Profit13.48
Enterprise Value/Ebitda-21.80
Forecast
1Y Price Target
$18.67Price Target Upside102.06% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Fennec Pharmaceuticals News
PremiumCompany Announcements
Fennec Pharmaceuticals Reports Strong 2023 Growth
PremiumCompany Announcements
Fennec Pharmaceuticals Files SEC 8-K Report
PremiumCompany Announcements
Fennec Pharmaceuticals’ Soaring Sales and New DealRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
FENC FAQ
What was Fennec Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Fennec Pharmaceuticals’s market cap?
Currently, no data Available
When is Fennec Pharmaceuticals’s upcoming earnings report date?
Fennec Pharmaceuticals’s upcoming earnings report date is May 09, 2024 which is in 14 days.
How were Fennec Pharmaceuticals’s earnings last quarter?
Fennec Pharmaceuticals released its earnings results on Mar 21, 2024. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of -$0.018 by -$0.082.
Is Fennec Pharmaceuticals overvalued?
According to Wall Street analysts Fennec Pharmaceuticals’s price is currently Undervalued.
Does Fennec Pharmaceuticals pay dividends?
Fennec Pharmaceuticals does not currently pay dividends.
What is Fennec Pharmaceuticals’s EPS estimate?
Fennec Pharmaceuticals’s EPS estimate is -$0.06.
How many shares outstanding does Fennec Pharmaceuticals have?
Currently, no data Available
What happened to Fennec Pharmaceuticals’s price movement after its last earnings report?
Fennec Pharmaceuticals reported an EPS of -$0.1 in its last earnings report, missing expectations of -$0.018. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Fennec Pharmaceuticals?
Currently, no hedge funds are holding shares in FENC
---
Fennec Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.67 (102.06% Upside)
$18.67 (102.06% Upside)
Blogger Sentiment
Neutral
FENC Sentiment 50%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $31.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.81%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.28%
Trailing 12-Months
Company Description
Fennec Pharmaceuticals
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
---
FENC Earnings Call
Q4 2024
0:00 / 0:00
---
FENC Stock 12 Months Forecast
Average Price Target
$18.67
▲(102.06% Upside)
Technical Analysis
Best Analysts Covering FENC
1 Year
1 Year Success Rate
9/11 ratings generated profit
1 Year Average Return
+14.48%
assigned a buy rating last month
Copying Chase Knickerbocker's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +14.48% per trade.
---